Contact this trialFirst, we need to learn more about you.
MEK Inhibitor
Trametinib for Advanced Cancer
Recruiting1 awardPhase 1
Tampa, Florida
This trial is testing whether a drug called trametinib can help treat patients with advanced cancer that has spread and usually can't be cured or controlled. Trametinib may stop the growth of tumor cells by blocking proteins needed for cell growth. Hepatic dysfunction is common in patients with advanced cancer and usually prevents them from receiving standard treatments or participating in clinical trials. Trametinib may be a better treatment for these patients.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.